Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC
Agreement drives continued patient access to four important therapies in Japan and KoreaStrengthens Essential Pharma and Clinigen’s combined ...
Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board
The new Executive Board, appointed unanimously by the Supervisory Board, has been purposely streamlined and will focus on the final stages of ZEPIZURE®'s registration with the FDA, a key step in ...
pharmaphorum3d
What is pharmaceutical market access?
and to establish if there was broad uniformity in how market access was defined and developed. There were 104 responders, comprised of 50% from pharma, 41% from agencies and the remainder from ...
pharmaphorum1d
Market access challenges driving pharma change
As part of the research into our recent white paper on market access (published with Capgemini Consulting) we saw that pharmaceutical industries today have to deal with two contradictory trends ...
MM&M2d
Pharma brands are struggling to keep the attention of digitally savvy HCPs
It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...